Brief: BioArctic Q4 Operating Profit SEK -53.5 Million
13/02/2025 07:00
Feb 13 (Reuters) - BioArctic Q4 adjusted free cash flow SEK -27.4 million. * Q4 adjusted EPS SEK -0.36 * Q4 revenue SEK 101.2 million
Recent news on BioArctic AB (publ)
See all newsBrief: BioArctic Gets Leqembi Pen Subcutaneous Formulation Approval In Japan
Brief: BioArctic Says Leqembi Subcutaneous Formulation Approved For Initiation Treatment In China
Brief: BioArctic Says Canada's Drug Agency Issues Final Positive Recommendation Supporting Public Reimbursement Of Leqembi
Sweden's BioArctic Q2 revenue falls despite higher Leqembi royalties
Brief: BioArctic Q2 Net Sales Down At SEK 247.5 Mln